Optibio Co., Ltd of Cheongju-si at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Premium Exhibitor

Optibio Co., Ltd

Chungbuk Tp Bonbukwan-409, 76, Yeongudan Ji-Ro, Cheongwon-Gu, Cheongju-si, 28116 Cheongju-si
Korea, Republic
Telephone +82 43 2177030
Fax +82 43 2177031
jm.park@optibio.co.kr

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Contact

MY Choi

Chief Executive Officer

Phone
+82-43-217-7030

Jay Park

Business Development Director

Phone
+82-43-217-7030

Email
jm.park@optibio.co.kr

PhD MJ Jeon

R&D Executive Director

Phone
+82-33-258-6060

Jongho Son

Business Development Manager

Phone
+82-43-217-7030

Email
jhson@optibio.co.kr

Our range of products

Product categories

  • 02  Laboratory technology
  • 02.01  Analyser systems / equipment

Analyser systems / equipment

  • 02  Laboratory technology
  • 02.09  Laboratory equipment

Laboratory equipment

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing
  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Our products

Product category: Analyser systems / equipment, Immuno assay testing, Diagnostic rapid tests

Optical Q™

The Optical Q™ is a cutting edge POC in-vitro diagnostics fluorescence immunoassay analyzer that accurately measures the concentration of analytes contained in blood, serum, plasma, and other samples.

 
TECHNICAL HIGHLIGHTS

-- Easy and simple (3 steps: dilution, drop, analysis)
-- Instantaneous results (results within a few minutes)
-- Top sensitivity and specificity (Immunofluorescence technology)
-- Wide variety of tests (Inflammation, diabetes, vitamin D and 25 more test)

More Less

Product category: Analyser systems / equipment, Diagnostic rapid tests

Optical Q™ HbA1c

The Optical Q™ HbA1c test is a proprietary point-of-care immunoassay designed for prompt and accurate in vitro quantitative measurement of HbA1c.


TECHNICAL HIGHLIGHTS

-- Approved by CE (IVD)
-- Rapid and quantitative immunoassay
-- High performance of CV < 10%
-- Assay time of 15 minutes
-- 25 Tests/Kit

More Less

Product category: Immuno assay testing, Diagnostic rapid tests

Optical Q™ Vitamin D

The Optical Q™ Vitamin D test is a proprietary point-of-care immunoassay designed for prompt and accurate in vitro quantitative measurement of total 25-hydroxy(OH) Vitamin D.


TECHNICAL HIGHLIGHTS

-- Approved by CE, MSDS Korea
-- Rapid and quantitative immunoassay
-- High performance of CV < 10%
-- Assay time of 25 minutes (includes 2 assays)
-- 25 Tests/Kit

More Less

Product category: Immuno assay testing, Diagnostic rapid tests

Optical Q™ PCT

The Optical Q™ PCT test is a proprietary point-of-care immunoassay designed for prompt and accurate in vitro quantitative measurement of procalcitonin (PCT).

 
TECHNICAL HIGHLIGHTS

-- Approved by CE, MSDS Korea
-- Rapid and quantitative immunoassay
-- High performance of CV < 10%
-- Assay time of 15 minutes
-- 25 Tests/Kit

More Less

Product category: Immuno assay testing, Diagnostic rapid tests

Optical Q™ CRP

The Optical Q™ PCT test is a proprietary point-of-care immunoassay designed for prompt and accurate in vitro quantitative measurement of procalcitonin (PCT).

TECHNICAL HIGHLIGHTS

-- Approved by CE, MSDS Korea
-- Rapid and quantitative immunoassay
-- High performance of CV < 10%
-- Assay time of 3 minutes
-- 25 Tests/Kit

More Less

About us

Company details

OptiBio is a biotechnology company focused in researching, developing, and creating cutting edge fluorescence immunoassay solutions. In 2019, Optibio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach in product development. OptiBio's approach comprises of specialized teams of scientists and engineers dedicated to directly developing diagnostic markers, test kits, and analyzers, uniquely positioning OptiBio to optimize top solutions in point-of-care testing (POCT).

More Less

Company data

Sales volume

1-9 Mio US $

Export content

> 75%

Number of employees

20-49

Area of business

Diagnostics

Company information as a PDF file